109 results
Page 4 of 6
S-3ASR
EX-1.2
y4u2yv7 vtyp
18 May 21
Automatic shelf registration
6:01am
8-K
EX-99.2
7rzockd2t9y8qaham u2
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
EX-99.1
ai2 74de0
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
EX-99.1
0t0wr
13 Apr 21
A Global Disease, A Pioneering Treatment Corporate Presentation April 2021
8:30am
8-K
EX-99.1
pk5ag
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
sauw4qca3ngooo73hc
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.2
1h8t1ckq
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
8z4ty1
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
EX-99.1
9ujoam jka3oz9pa
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
3r4xli
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am
8-K
EX-99.1
eh69 7o8nl
12 Nov 20
Akero Therapeutics Reports THIRD Quarter 2020 Financial Results
4:20pm
8-K
EX-99.1
ylllk9
15 Oct 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation October 2020
8:30am
8-K
EX-99.1
ip3vghftwakfpcpu
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm
8-K
EX-99.1
sd9 iwl27ri
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm